Skip to main content
. 2019 Nov 25;221(7):1070–1078. doi: 10.1093/infdis/jiz333

Table 2.

Proportion (%) Positive Vaccine Take by Lewis and Secretor Status

Positive Vaccine Take Positive for Serum IgA and/or SNA Response Positive for Serum IgA Response Positive for SNA Response Positive for RV3-BB Virus Excretion
Phenotypea Participants, Proportion (%) RR (95% CI) P Participants, Proportion (%) RR (95% CI) P Participants, Proportion (%) RR (95% CI) P Participants, Proportion (%) RR (95% CI) P Participants, Proportion (%) RR (95% CI) P
Secretor phenotype (n = 46)
 Secretor 29/32 (91) Reference 21/32 (66) Reference 21/32 (66) Reference 4/31 (13) Reference 23/32 (72) Reference
 Nonsecretor 13/13 (100) 0.91 (.81–1.01) .25 11/13 (85) 0.76 (.55–1.09) .20 11/13 (85) 0.78 (.55–1.09) .20 3/11 (27) 0.47 (.13–1.79) .27 10/13 (77) 0.93 (.65–1.35) .73
 Weak secretor 1/1 (100) 1/1 (100) 1/1 (100) 0/1 (0) 1/1 (100)
Lewis phenotype (n = 43)
 Positive 37/40 (93) Reference 29/40 (73) 29/40 (73) 7/38 (18) 28/40 (70)
 Negative 3/3 (100) 0.93 (.85–1.01) .62 1/3 (33) 1/3 (33) 0/3 (0) 3/3 (100)
Combined phenotype (n = 43)
 Le, Se (Lewis positive, secretor) 25/28 (89) Reference 19/28 (68) Reference 19/28 (68) Reference 4/27 (15)j Reference 19/28 (68) Reference
 Le, se (Lewis positive, nonsecretor) 12/12 (100) 0.89 (.79–1.01) .24 10/12 (83) 0.81 (.57–1.17) .32 10/12 (83) 0.81 (.57–1.17) .32 3/11 (27)j 0.54 (.15–2.04) .37 9/12 (75) 0.91 (.60–1.37) .65
 le, Se (Lewis negative, secretor) 2/2 (100) 0/2 (0) 0/2 (0) 0/2 (0) 2/2 (100)
 le, sew (Lewis negative, weak secretor) 1/1 (100) 1/1 (100) 1/1 (100) 0/1 (0) 1/1 (100)
 le, se (Lewis negative, nonsecretor) 0 0 0 0 0

Phenotypes were inferred from genotype type data. See Methods for descriptions of secretor and Lewis phenotypes.

Abbreviations: CI, confidence interval; IgA, immunoglobulin A; le, nonfunctional FUT3; Le, at least 1 functional gene encoding FUT3; RR, relative risk; se, nonfunctional FUT2; Se, at least 1 functional gene encoding FUT2; SNA, serum neutralizing antibody.